Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: JACC Heart Fail. 2019 Dec 11;8(3):157–168. doi: 10.1016/j.jchf.2019.09.012

Table 4:

Adverse events

Adverse Event Total
Population
(n=60)
Metolazone
(n=20)
Chlorothiazide
(n=20)
Tolvaptan
(n=20)
SCr increase > 1mg/dl 4 1 3 0
Hypotension (SBP < 85mmHg) 4 2 0 2
Symptomatic Gout flare 3 0 0 3
Severe hypokalemia (Serum K+ < 3.0 mEq/L) 1 1 0 0
Myalgia/muscle cramping 5 2 2 1

K+= serum potassium, SBP = systolic blood pressure, SCr = serum creatinine